Metrikler
Yayın
21
Açık Erişim
7
BM Sürdürülebilir Kalkınma Amaçları
Makaleler
Tümü (13)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (13)
ESCI (1)
Scopus (12)
TRDizin (2)
2018
20181. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)
Inal A., Kodaz H., Odabas H., Duran A. O., ŞEKER M. M., Inanc M., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.14, sa.3, ss.578-582, 2018 (SCI-Expanded)
2017
20172. Efficacy and safety of cetuximab plus FOLFOX in second-line and third-line therapy in metastatic colorectal cancer
Ozaslan E., Topaloglu U. S., Inanc M., Erdem U. G., Demir H., Arpaci E., et al.
JOURNAL OF BUON
, cilt.22, sa.4, ss.863-868, 2017 (SCI-Expanded)
2017
20173. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors
Gumus M., Bilici A., Odabas H., Ustaalioglu B. B. O., Kandemir N., Demirci U., et al.
WORLD JOURNAL OF UROLOGY
, cilt.35, sa.7, ss.1103-1110, 2017 (SCI-Expanded)
2016
20164. The Diagnostic Value of the Correlation between Serum Anti-p53 Antibody and Positron Emission Tomography Parameters in Lung Cancer
HASBEK Z., DOĞAN Ö. T., San I., YÜCEL B., Seker M. M., TURGUT B., et al.
MOLECULAR IMAGING AND RADIONUCLIDE THERAPY
, cilt.25, sa.3, ss.107-113, 2016 (ESCI, TRDizin)
2016
20165. The prognostic value of UHRF-1 and p53 in gastric cancer
AKGÜL BABACAN N., EĞİLMEZ H. R., YÜCEL B., Parlak I., ŞEKER M. M., KAÇAN T., et al.
SAUDI JOURNAL OF GASTROENTEROLOGY
, cilt.22, sa.1, ss.25-29, 2016 (SCI-Expanded, Scopus)
2014
20146. Oxaliplatin and ototoxicity: is it really safe for hearing?
YÜCE S., ŞEKER M. M., KOÇ S., UYSAL İ. Ö., KAÇAN T., DOĞAN M., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES
, cilt.44, sa.4, ss.586-589, 2014 (SCI-Expanded, Scopus, TRDizin)
2014
20147. Clinicopathologic Features and Prognosis of Osteosarcoma in Turkish Adults
ŞEKER M. M., Seker A., AKSOY S., Ozdemir N., Uncu D., Zengin N.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.8, ss.3537-3540, 2014 (SCI-Expanded, Scopus)
2014
20148. Lung Cancer in Women: A Single Institution Experience with 50 Patients
Babacan N. A., YÜCEL B., KILIÇKAP S., Seker M. M., Kacan T., Olcas I. K., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.1, ss.151-154, 2014 (SCI-Expanded, Scopus)
2014
20149. Recurrence Risk and Prognostic Parameters in Stage I Rectal Cancers
Cihan S., KÜÇÜKÖNER M., ÖZDEMİR N., DANE F., ŞENDUR M. A. N., Yazilitas D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.13, ss.5337-5341, 2014 (SCI-Expanded)
2014
201410. Treatment and Outcomes of Ewing Sarcoma in Turkish Adults: A Single Centre Experience
ŞEKER M. M., Kos T., Ozdemir N., Seker A., AKSOY S., Uncu D., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.1, ss.327-330, 2014 (SCI-Expanded)
2014
201411. Investigation of Antitumor Effects of Sorafenib and Lapatinib Alone and in Combination on MCF-7 Breast Cancer Cells
KAÇAN T., Altun A., Altun G. G., Kacan S. B., Sarac B., ŞEKER M. M., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.15, sa.7, ss.3185-3189, 2014 (SCI-Expanded)
2013
201312. Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients
Durnali A., Alkis N., CANGÜR Ş., Yukruk F. A., Inal A., Tokluoglu S., et al.
MEDICAL ONCOLOGY
, cilt.30, sa.3, 2013 (SCI-Expanded, Scopus)
2013
201313. Survival Analysis and Prognostic Factors for Neuroendocrine Tumors in Turkey
YÜCEL B., AKGÜL BABACAN N., KAÇAN T., AY EREN A., EREN M. F., BAHAR S., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION
, cilt.14, sa.11, ss.6687-6692, 2013 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2016
20161. Is there diagnostic and prognostic importance of serum anti p53 antibody level in lung cancer
HASBEK Z., TURGUT B., DOĞAN Ö. T., YÜCEL B., BERK S., Sarı İ., et al.
Annual Congress of the European Association of Nuclear Medicine, 15 - 19 Ekim 2016, (Özet Bildiri)
2015
20152. What are the differences between young (25 years) and adults (> 25 years) colorectal cancer (CRC)? An Anatolian Society of Medical Oncology Study.
Kaplan M. A., Urakci Z., Gumus M., Arslan U. Y., Geredeli C., Ozdemir N., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) / Clinical Science Symposium on Predicting and Improving Adverse Outcomes in Older Adults with Cancer, Illinois, Amerika Birleşik Devletleri, 29 Mayıs - 02 Haziran 2015, cilt.33
2014
20143. Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology
Demirci U., Oflazoglu U., Kodaz H., Ciltas A., Kefeli U., Akyol M., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
20144. The diagnostic and prognostic value of UHRF-1 and p53 in gastric cancer.
Babacan N. A., Egilmez R., Yucel B., Seker M. M., Parlak I., Kacan T., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
20145. Prognostic value of serum TIE-2 and vascular endothelial growth factor levels in gastric cancer patients.
Seker M. M., Sancakdar E., Seker A., Bahceci A., Kacan T., Babacan N.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2014
20146. Could the neutrophil to lymphocyte ratio be a poor prognostic factor for lung cancers?
Kacan T., Babacan N., Seker M. M., Yucel B., Behceci A., Gedikil M. A., et al.
50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32, (Özet Bildiri)
2013
20137. Larenks Kanserinde Tedavi Sonuçlarımız
YÜCEL B., AKKAŞ E., ERDİŞ E., AY EREN A., EREN M. F., AKGÜL BABACAN N., et al.
20. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2013, ss.247, (Özet Bildiri)